00For this year the analysts expect a dividend of 3.13 USD per share. Thus the dividend yield equals 4.67 percent. The average dividend yield of the biotech companies equals an attractive 3.55 percent.
Tomorrow the American Gilead Sciences will report its past quarters results. Over the current book year the company from Foster City could achieve a revenue around 27.49 billion USD (consensus estimates). This is slightly more than 2023's revenue of 27.12 billion USD.
Gilead Sciences Kite The Netherlands © Gilead Sciences |
The analysts expect for 2024 a net profit of 4.86 billion USD. For this year most of the analysts expect a profit per share of 3.89 USD. Based on this the price/earnings-ratio is 17.23.
Based on the current number of shares Gilead Sciences 's market capitalization equals 83.59 billion USD.
Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.